Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Impact of Sativex(®) on quality of life and activities of daily living in patients with multiple sclerosis spasticity.
NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis.
Is the use of the trivalent influenza vaccine against A (H1N1) pdm09 associated with an increased risk of post-vaccination acute disseminated encephalomyelitis?
A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci.
ApoE-Deficient Promotes Blood-Brain Barrier Disruption in Experimental Autoimmune Encephalomyelitis via Alteration of MMP-9.
Value, challenges, and satisfaction of certification for multiple sclerosis specialists.
4-Aminopyridine for symptomatic treatment of multiple sclerosis: a systematic review.
Transient hyperCKemia in the setting of neuromyelitis optica (NMO).
Does lesioning surgery have a role in the management of multietiological tremor in the era of Deep Brain Stimulation?
Early onset (childhood) monogenic neuropathies.
Quick screening of cognitive function in Indian multiple sclerosis patients using Montreal cognitive assessment test-short version.
Confronting Patients About Insufficient Effort: The Impact on Subsequent Symptom Validity and Memory Performance.
GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia.
Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis.
Retrieval practice is a robust memory aid for memory-impaired patients with MS.
Gatekeeper role of brain antigen-presenting CD11c+ cells in neuroinflammation.
Cannabidiol: promise and pitfalls.
Carbon Nanotube-Bilirubin Oxidase Bioconjugate as a New Biofuel Cell Label for Self-Powered Immunosensor.
Identifying Modulators of CXC Receptors 3 and 4 with Tailored Selectivity using Multi-Target Docking.
Dynamics of oligodendrocyte generation and myelination in the human brain.
Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes.
Can we measure long-term treatment effects in multiple sclerosis?
Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics.
Promoting sympathovagal balance in multiple sclerosis; pharmacological, non-pharmacological, and surgical strategies.
A Case of Anti-aquaporin-4 Antibody-Seronegative NMO Spectrum Disorder with Baló Concentric Lesions.
Pages
« first
‹ previous
…
383
384
385
386
387
388
389
390
391
…
next ›
last »